Discover 861 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 861
Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)
for
Hepatic Impairment, Moderate Hepatic Impairment
Location: Orlando FL, San Antonio TX
Sponsor: Exelixis
Sex: All
Age: 18 - 70+
Code: NCT06962332
Phase1, Recruiting
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
for
Muscular Atrophy, Spinal
Location: Orlando FL, Norfolk VA, Charlottesville VA, Hershey PA,
Sponsor: Biogen
Sex: All
Age: 3+
Code: NCT06555419
Phase1, Recruiting
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Orlando FL, Jacksonville FL, Tampa FL, Nashville TN,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05932862
Phase1, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Orlando FL, Birmingham AL, Nashville TN, New York NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase1, Recruiting
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
for
Solid Tumors
Location: Orlando FL, Huntersville NC, Washington D.C. DC,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07123103
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Orlando FL, Jacksonville FL, Palm Bay FL,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase2, Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Orlando FL, Tampa FL, Loxahatchee Groves FL,